CareDx Q1 Revenues Grow 22 Percent | GenomeWeb

NEW YORK (GenomeWeb) – CareDx said after the close of the market on Tuesday that its first quarter revenues grew 22 percent year over year. 

For the three months ended March 31, the Brisbane, California-based molecular diagnostics firm posted $7.2 million in revenues, up from $5.9 million in Q1 2014, and beating the consensus Wall Street estimate of $6.8 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.